The Channing Laboratory selects LabVantage's Sapphire
17 July 2008Tweet
LabVantage Solutions has supplied its Sapphire BioBanking Solution to the Channing Laboratory, a multidisciplinary research division of Brigham and Women's Hospital and Harvard Medical School. The laboratory is world-renowned for its research into infectious diseases and epidemiology. As part of a laboratory information management project, it will deploy Sapphire in the Respiratory Epidemiology Genotyping Laboratory, replacing significant portions of the existing LIMS and other internally developed software packages.
The BioBanking Module is tailored for biorepository management. The zero footprint, thin-client architecture will provide technicians, scientists, and principal investigators with remote and secure access when interacting with the biorepository. Sapphire was also selected for its ability to map existing laboratory processes to its built-in workflow management capabilities. This would enable The Channing Laboratory to automate its study management, sample collection, accessioning, and storage management practices and ensure compliance with its standard operating procedures.
'We were primarily seeking a solution for our biorepository needs, but quickly found that many of our internally built laboratory systems and process would be tied to the biorepository processes,' commented Dr Scott Weiss, principal investigator for the Channing Laboratory. 'We needed a solution that would provide state-of-the-art biorepository management and that would also replace our legacy systems with standardised solutions.'